Public Health Agency of Canada

This document also discusses an approach to managing COVID-19 vaccines that are administered in a manner that differs from the recommendations of the manufacturer as authorized by Health Canada and/or the recommendations for use by National Advisory Committee on Immunization (NACI). These are...

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed in this document.

Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in Interim Order No. 2. Health Canada maintains and updates the list as required. It’s the same list that was incorporated by reference in the previous IO...

This is a link to multiple publications of diseases and conditions in Canada.

This guidance supports high quality investigations that will contribute to public health’s collective understanding of COVID-19 transmission in all types of school settings and the utility of mitigation measures implemented. A systematic approach to outbreak response, including an investigation...

This document outlines the recommended goals, objectives, and activities for COVID-19 surveillance in Canada. These guidelines are based on current available scientific evidence and expert opinion and are subject to change as new information becomes available. They should be read in conjunction...

COVID-19 information for physicians, nurses, pharmacists and other health care providers.

We have developed a guidance for managing COVID-19. This guidance is for: health professionals who manage clinical care, and infection prevention and control within health care facilities, health professionals who develop public health advice, policies and programs, and a broad range of sectors,...